Clinical trial retention remains one of the biggest challenges facing biopharmaceutical companies today. While recruitment often receives the most attention, retaining participants through study completion is equally critical. High dropout rates can delay timelines, increase costs, and compromise data integrity. The most effective way to reduce attrition is simple in theory, but complex in practice: meaningful, ongoing patient engagement.